Main Content start here
Main Layout
Report Description

Report Description

Asia Pacific artificial organs and bionics market is expected to grow at a significant rate during the forecast period, 2024-2028. Rising cases of organ failures, along with scarcity of organ donors are anticipated to facilitate the growth of the market. For instance, according to the article titled “Organ donation in India – There is light at the end of the tunnel” published in 2022, it is projected that every year, approximately 5 lakh Indians face organ failures, still less than 2%-3% of them receive a life-saving transplant.  Moreover, increasing cases of disabilities or road accidents which leads to amputations, are surging the demand for the replacement of the damaged part or organ, which, in turn, is bolstering the growth of the market. The rising adoption of advanced technologies such as 3D bioprinting, artificial intelligence, and others are propelling the growth of the Asia-pacific artificial organs and bionics market. However, compatibility issues between the organ donor and a transplant recipient are hampering the growth of the market. Besides, strict regulations associated with the artificial organs and bionics are expected to slow down the growth of the market.

Asia Pacific artificial organs and bionics market is segmented into product, technology, material, end-user, company, and country. The product segment is further divided into artificial heart, artificial kidney, artificial thyroid gland, bionic limb, and others. Artificial kidneys held the dominant share in 2022, due to the increasing renal diseases, and failures, and growing elderly population. Based on country, Japan holds the maximum share of the market in the Asia Pacific region. This is attributed to the increase in the number of chronic diseases that lead to organ failure, rising older population, and increasing rate of road mishaps and resulting disabilities.

Major players in the artificial organs and bionics market of Asia Pacific include Medtronic plc, Getinge AB, Ekso Bionics Holdings Inc., Boston Scientific Corporation, ABIOMED, Rex Bionics Ltd, Össur hf, ReWalk Robotics, Cyberdyne Inc., and Obara Kogyo Inc. Ltd. Collaboration and mergers with medical schools or research organizations is one of the key strategies of the companies to sustain and maintain their position in such highly competitive environment.


Download Free Sample Report

Objective of the Study:

  • To analyze and forecast the market size of Asia Pacific artificial organs and bionics market.
  • To classify and forecast Asia Pacific artificial organs and bionics market based on product, technology, material, end-user, company and country.
  • To identify drivers and challenges for Asia Pacific artificial organs and bionics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Asia Pacific artificial organs and bionics market.
  • To conduct pricing analysis for Asia Pacific artificial organs and bionics market.
  • To identify and analyze the profile of leading players operating in Asia Pacific artificial organs and bionics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and surgical centers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and surgical centers which could not be identified due to the limitations of secondary research. TechSci Research analyzed hospitals and surgical centers and presence of all major players across the globe.

TechSci Research calculated the market size of Asia Pacific artificial organs and bionics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Hospitals, surgical centers, organ banks/distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to artificial organs and bionics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and surgical centers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, Company share, Competitive landscape, Growth factors, and Trends

Segments covered

Product

Technology

Material

End User

Region

Country scope

China, India, Japan, South Korea, Singapore, Australia, Vietnam, Malaysia, Indonesia, Philippines

Key companies profiled

Medtronic plc, Getinge AB, Ekso Bionics Holdings Inc., Boston Scientific Corporation, ABIOMED, Rex Bionics Ltd, Össur hf, ReWalk Robotics, Cyberdyne Inc., and Obara Kogyo Inc. Ltd.

Customization scope

10% free report customization with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 Report Scope:

In this report, Asia Pacific artificial organs and bionics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Asia Pacific Artificial Organs and Bionics Market, By Products:
    • Artificial Heart
    • Artificial Kidneys
    • Bionic Limb
    • Others
  • Asia Pacific Artificial Organs and Bionics Market, By Technology:
    • Suction Technology
    • Implanted myoelectric sensor (IMES) technology
    • Socket-Based Technology
    • 3D Bioprinting
    • Others
  • Asia Pacific Artificial Organs and Bionics Market, By Material:

o   Plastics

o   Metal

o   Polymer

  • Asia Pacific Artificial Organs and Bionics Market, By End User:
    • Hospitals
    • Surgical Centers
    • Others
  • Asia Pacific Artificial Organs and Bionics Market, By Country:
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Australia
    • Vietnam
    • Malaysia
    • Indonesia
    • Philippines

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Asia Pacific artificial organs and bionics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Asia Pacific Artificial Organs and Bionics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Products (Artificial heart, Artificial Kidneys, Bionic Limb, and Others)

5.2.2.     By Technology (Suction Technology, Implanted myoelectric sensor (IMES) technology, Socket-Based Technology, 3D Bioprinting and Others)

5.2.3.     By Material (Plastics, Metal, Polymer, and Others)

5.2.4.     By End-User (Hospitals, Surgical Centers and Others)

5.2.5.     By Company (2022)

5.2.6.     By Country  

5.3.  Market Map

5.3.1.     By Products

5.3.2.     By Technology

5.3.3.     By Material

5.3.4.     By End User

5.3.5.     By Country

5.4.  Asia Pacific: Country Analysis

5.4.1.     China Artificial Organs and Bionics Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Products

5.4.1.2.2.             By Technology

5.4.1.2.3.             By Material

5.4.1.2.4.             By End-User

5.4.2.     India Artificial Organs and Bionics Market Outlook

5.4.2.1.         Market Size & Forecast

5.4.2.1.1.             By Value

5.4.2.2.         Market Share & Forecast

5.4.2.2.1.             By Products

5.4.2.2.2.             By Technology

5.4.2.2.3.             By Material

5.4.2.2.4.             By End-User

5.4.3.     Japan Artificial Organs and Bionics Market Outlook

5.4.3.1.         Market Size & Forecast

5.4.3.1.1.             By Value

5.4.3.2.         Market Share & Forecast

5.4.3.2.1.             By Products

5.4.3.2.2.             By Technology

5.4.3.2.3.             By Material

5.4.3.2.4.             By End-User

5.4.4.     South Korea Artificial Organs and Bionics Market Outlook

5.4.4.1.         Market Size & Forecast

5.4.4.1.1.             By Value

5.4.4.2.         Market Share & Forecast

5.4.4.2.1.             By Products

5.4.4.2.2.             By Technology

5.4.4.2.3.             By Material

5.4.4.2.4.             By End-User

5.4.5.     Singapore Artificial Organs and Bionics Market Outlook

5.4.5.1.         Market Size & Forecast

5.4.5.1.1.             By Value

5.4.5.2.         Market Share & Forecast

5.4.5.2.1.             By Products

5.4.5.2.2.             By Technology

5.4.5.2.3.             By Material

5.4.5.2.4.             By End-User

5.4.6.     Australia Artificial Organs and Bionics Market Outlook

5.4.6.1.         Market Size & Forecast

5.4.6.1.1.             By Value

5.4.6.2.         Market Share & Forecast

5.4.6.2.1.             By Products

5.4.6.2.2.             By Technology

5.4.6.2.3.             By Material

5.4.6.2.4.             By End-User

5.4.7.     Vietnam Artificial Organs and Bionics Market Outlook

5.4.7.1.         Market Size & Forecast

5.4.7.1.1.             By Value

5.4.7.2.         Market Share & Forecast

5.4.7.2.1.             By Products

5.4.7.2.2.             By Technology

5.4.7.2.3.             By Material

5.4.7.2.4.             By End-User

5.4.8.     Malaysia Artificial Organs and Bionics Market Outlook

5.4.8.1.         Market Size & Forecast

5.4.8.1.1.             By Value

5.4.8.2.         Market Share & Forecast

5.4.8.2.1.             By Products

5.4.8.2.2.             By Technology

5.4.8.2.3.             By Material

5.4.8.2.4.             By End-User

5.4.9.     Indonesia Artificial Organs and Bionics Market Outlook

5.4.9.1.         Market Size & Forecast

5.4.9.1.1.             By Value

5.4.9.2.         Market Share & Forecast

5.4.9.2.1.             By Products

5.4.9.2.2.             By Technology

5.4.9.2.3.             By Material

5.4.9.2.4.             By End-User

5.4.10.  Philippines Artificial Organs and Bionics Market Outlook

5.4.10.1.      Market Size & Forecast

5.4.10.1.1.           By Value

5.4.10.2.      Market Share & Forecast

5.4.10.2.1.           By Products

5.4.10.2.2.           By Technology

5.4.10.2.3.           By Material

5.4.10.2.4.           By End-User

6.    Market Dynamics

6.1.  Drivers

6.2.  Challenges

7.    Market Trends & Developments

8.    Competitive Landscape

8.1.  Competition Outlook

8.2.  Company Profiles

8.2.1.     Medtronic plc

8.2.2.     Getinge AB

8.2.3.     Ekso Bionics Holdings Inc.

8.2.4.     Boston Scientific Corporation

8.2.5.     ABIOMED.

8.2.6.     Rex Bionics Ltd

8.2.7.     Össur hf

8.2.8.     ReWalk Robotics

8.2.9.     Cyberdyne Inc.

8.2.10.  Obara Kogyo Inc. Ltd.

9. Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

Rising prevalence of organ failures, and technological advancements leading to enhanced applications are expected to drive Asia Pacific artificial organs and bionics market during forecast period.

Asia Pacific artificial organs and bionics market is segmented into product, technology, material, end-user, company, and country.

Based on product segment, artificial kidneys segment is expected to anticipate the growth of the Asia Pacific artificial organs and bionics market during forecast period. This is due to the increasing renal diseases, and failures, and growing elderly population.

Major companies operating in Asia Pacific artificial organs and bionics market include Medtronic plc, Getinge AB, Ekso Bionics Holdings Inc., Boston Scientific Corporation, ABIOMED, Rex Bionics Ltd, Össur hf, ReWalk Robotics, Cyberdyne Inc., and Obara Kogyo Inc. Ltd.

Related Reports